summary
Introduced
In Committee
Crossed Over
Passed
Dead
Introduced Session
2013 Regular Session
Bill Summary
Permitting a class II institutional pharmacy formulary to include biologics, biosimilars, and biosimilar interchangeables; providing requirements for a pharmacist to dispense a substitute biological product that is determined to be biosimilar to and interchangeable for the prescribed biological product; providing notification requirements for a pharmacist in a class II or modified class II institutional pharmacy; requiring the Board of Pharmacy to maintain a current list of interchangeable biosimilar products, etc.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (1)
Other Sponsors (2)
Appropriations (S), Health Policy (S)
Last Action
Laid on Table, companion bill(s) passed, see CS/CS/HB 365 (Ch. 2013-102) (on 04/29/2013)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...